| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1470-2045(02)00931-2 |
| P698 | PubMed publication ID | 12473516 |
| P50 | author | Carlo Maria Croce | Q640381 |
| P2093 | author name string | Kay Huebner | |
| Nicola Zanesi | |||
| Alexey Palamarchuk | |||
| Yuri Pekarsky | |||
| P2860 | cites work | Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer | Q41332396 |
| Origin of genes encoding multi-enzymatic proteins in eukaryotes. | Q41549764 | ||
| Molecular follow-up of preneoplastic lesions in bronchial epithelium of former Chernobyl clean-up workers | Q43955974 | ||
| The FHIT gene 3p14.2 is abnormal in lung cancer | Q53455201 | ||
| Time-resolved X-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysis | Q58072287 | ||
| Tumor suppressor genes | Q68264184 | ||
| Role of chromosome translocations in human neoplasia | Q68818574 | ||
| Involvement of the bcl-2 gene in human follicular lymphoma | Q69870224 | ||
| Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(FRA3B) in lymphocytes | Q70378721 | ||
| Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma | Q70449918 | ||
| Clonal genetic alterations in the lungs of current and former smokers | Q73443322 | ||
| The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma | Q73549634 | ||
| Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction | Q74306391 | ||
| The tumor suppressor protein Fhit. A novel interaction with tubulin | Q78122448 | ||
| Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit | Q24313542 | ||
| Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans | Q24317206 | ||
| Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase | Q24320228 | ||
| The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers | Q24321912 | ||
| The tumor spectrum in FHIT-deficient mice | Q24555215 | ||
| Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit | Q24595534 | ||
| Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene | Q24644705 | ||
| Muir-Torre-like syndrome in Fhit-deficient mice | Q24676755 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| Replacement of Fhit in cancer cells suppresses tumorigenicity | Q33726007 | ||
| The histidine triad superfamily of nucleotide-binding proteins | Q33738439 | ||
| Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability | Q33963998 | ||
| Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines | Q34019362 | ||
| Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies | Q34442403 | ||
| FHIT gene therapy prevents tumor development in Fhit-deficient mice. | Q34729169 | ||
| The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control | Q35552007 | ||
| Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. | Q36396981 | ||
| The use of epidemiology, scientific data, and regulatory authority to determine risk factors in cancer of some organs of the digestive system. 2. Esophageal cancer | Q36489743 | ||
| Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features | Q36621318 | ||
| Sequence of the FRA3B common fragile region: Implications for the mechanism of FHIT deletion | Q36827321 | ||
| Chromosome aberrations and cancer | Q37538405 | ||
| Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites | Q37559058 | ||
| Frequent altered expression of fragile histidine triad protein in human colorectal adenomas | Q40843340 | ||
| P433 | issue | 12 | |
| P921 | main subject | prevention | Q1717246 |
| gene discovery | Q129262352 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 748-754 | |
| P577 | publication date | 2002-12-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Lancet Oncology Commission | Q13747613 |
| P1476 | title | FHIT: from gene discovery to cancer treatment and prevention | |
| P478 | volume | 3 |
| Q44683356 | 5'-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas |
| Q60035707 | A prognostic DNA signature for T1T2 node-negative breast cancer patients |
| Q30543570 | Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor. |
| Q61809987 | Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma |
| Q37708066 | Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis |
| Q40414760 | Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines |
| Q30670527 | Association of activated Gαq to the tumor suppressor Fhit is enhanced by phospholipase Cβ |
| Q38614582 | CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer |
| Q33531934 | Chromosomal imbalances are uncommon in chagasic megaesophagus |
| Q44614687 | Chromosome arm 8p and cancer: a fragile hypothesis. |
| Q34156955 | Comparative analysis of algorithms for integration of copy number and expression data |
| Q45103584 | Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma. |
| Q46497555 | Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome |
| Q28252440 | Expression characteristics of FHIT, p53, BRCA2 and MLH1 in families with a history of oesophageal cancer in a region with a high incidence of oesophageal cancer |
| Q40368333 | Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR. |
| Q35147070 | Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements |
| Q43275576 | FHIT gene sequence variants and reduced Fhit protein expression in glioblastoma multiforme |
| Q44827323 | FHIT mRNA and protein expression in hepatocellular carcinoma |
| Q46235892 | FHIT promoter DNA methylation and expression analysis in childhood acute lymphoblastic leukemia |
| Q35191084 | FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells |
| Q40274111 | Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines |
| Q39771185 | Fhit regulates invasion of lung tumor cells |
| Q37352008 | Fhit tumor suppressor: guardian of the preneoplastic genome |
| Q33761959 | Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells |
| Q46733687 | Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas |
| Q35877178 | Gallbladder cancer: lessons from a rare tumour |
| Q38078472 | Genetic expression profiles of adult and pediatric ependymomas: Molecular pathways, prognostic indicators, and therapeutic targets |
| Q28728573 | Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation |
| Q37948622 | HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis. |
| Q57261261 | High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes |
| Q83820573 | High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia |
| Q42258973 | Human papillomavirus and non-small cell lung cancer |
| Q34444611 | Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer |
| Q34118625 | Identification of putative cancer genes through data integration and comparative genomics between plants and humans. |
| Q37272413 | Identification of the HIT-45 protein from Trypanosoma brucei as an FHIT protein/dinucleoside triphosphatase: substrate specificity studies on the recombinant and endogenous proteins |
| Q34650922 | Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine |
| Q46489933 | Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma |
| Q48117196 | Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean population |
| Q34382463 | Loss of FHIT expression in gastric mucosa of patients with family histories of gastric cancer and Helicobacter pylori infection |
| Q44623571 | Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer. |
| Q33866516 | Loss of fragile histidine triad protein expression in inflammatory bowel disease |
| Q36655128 | Methylation in esophageal carcinogenesis |
| Q37313424 | Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy |
| Q34212683 | Premature condensation induces breaks at the interface of early and late replicating chromosome bands bearing common fragile sites |
| Q37354050 | Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma |
| Q35563102 | Search for unknown tumor‐antagonizing genes |
| Q26828610 | Serine, glycine and one-carbon units: cancer metabolism in full circle |
| Q40339478 | Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia |
| Q36610527 | The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions |
| Q36299944 | The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity. |
| Q35112786 | Transcriptional profiling of the cell cycle checkpoint gene krüppel-like factor 4 reveals a global inhibitory function in macromolecular biosynthesis |
| Q92920001 | Translatable gene therapy for lung cancer using Crispr CAS9-an exploratory review |
| Q97532078 | Upregulation of FHIT gene expression in endometrial carcinoma by RNA activation |
| Q21283974 | Widespread presence of "bacterial-like" PPP phosphatases in eukaryotes |
Search more.